Advertisement

Uterine Cancer pp 307-309 | Cite as

Posttreatment Surveillance in Endometrial Cancer

  • Bindiya Gupta
  • Shalini Rajaram

Abstract

Routine surveillance is aimed to detect recurrence early and institute treatment In addition, follow-up also helps to diagnose treatment complications and provide psychological support for the patient. Most of the endometrial cancer recurrences, mostly vaginal cuff, occur within 3 years of diagnosis of primary tumor and 50–80 % of them are symptomatic [7–9]. The surveillance guidelines are more intensive for the first 5 years posttreatment.

Keywords

Endometrial Cancer National Comprehensive Cancer Network Endometrial Carcinoma National Comprehensive Cancer Network Routine Surveillance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.CrossRefPubMedGoogle Scholar
  2. 2.
    Balasubramaniam G, Sushama S, Rasika B, Mahantshetty U. Hospital-based study of endometrial cancer survival in Mumbai, India. Asian Pac J Cancer Prev. 2013;14(2):977–80.CrossRefPubMedGoogle Scholar
  3. 3.
    Greer BE, Golff BA, Koh WJ. Endometrial carcinoma. In: Johnson FR, Virgo KS, editors. Cancer patient follow up. St. Louis: Mosby; 1997. p. 357–77.Google Scholar
  4. 4.
    Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2006;24(1):36–44.CrossRefPubMedGoogle Scholar
  5. 5.
    Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92(3):744–51.CrossRefPubMedGoogle Scholar
  6. 6.
    Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, et al., POTEC Study Group. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol. 2003;89(2):201–9.Google Scholar
  7. 7.
    Sartori E, Pasinetti B, Chiudinelli F, Gadducci A, Landoni F, Maggino T, et al. Surveillance procedures for patients treated for endometrial cancer: a review of literature. Int J Gynecol Cancer. 2010;20(6):985–92.CrossRefPubMedGoogle Scholar
  8. 8.
    Sartori E, Passinett B, Carrara L, Gambino A, Odicino F, Percorelli S. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. Gynecol Oncol. 2007;107:S241–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Smith CJ, Heeren M, Nicklin JL, Perrin LC, Land R, Crandon AJ, et al. Efficacy of routine follow-up in patients with recurrent uterine cancer. Gynecol Oncol. 2007;107(1):124–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Plataniotis G, Castiglione M, ESMO Guidelines Working Group. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21 Suppl 5:v41–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Teng N, Greer B, Kapp D, Kavanagh J, Koh WJ. NCCN practice guidelines for endometrial carcinoma. Oncology. 1999;13:45.Google Scholar
  12. 12.
    American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 65: clinical management guidelines for obstetrician- gynecologists, August 2005: management of endometrial cancer. Obstet Gynecol. 2005;106:413–25.CrossRefGoogle Scholar
  13. 13.
    Agboola OO, Grunfeld E, Coyle D, Perry GA. Costs and benefits of routine follow-up after curative treatment for endometrial cancer. Can Med Assoc J. 1997;157:879–86.Google Scholar
  14. 14.
    Salani R, Backes FJ, Fung MF, Holschneider CH, Parker LP, Bristow RE, Goff BA. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol. 2011;204(6):466–78.CrossRefPubMedGoogle Scholar
  15. 15.
    Morice P, Levy-Piedbois C, Ajaj S, Pautier P, Haie-Meder C, Lhomme C, et al. Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer. Eur J Cancer. 2001;37(8):985–90.CrossRefPubMedGoogle Scholar
  16. 16.
    Sartori E, Laface B, Gadducci A, Maggino T, Zola P, Landoni F, Zanagnolo V. Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force (CTF) study. Int J Gynecol Cancer. 2003;13(4):458–65.CrossRefPubMedGoogle Scholar
  17. 17.
    Amit A, Schink J, Reiss A, Lowenstein L. PET/CT in gynecologic cancer: present applications and future prospects – a clinician’s perspective. Obstet Gynecol Clin North Am. 2011;38(1):1–21.CrossRefPubMedGoogle Scholar
  18. 18.
    Kadkhodayan S, Shahriari S, Treglia G, Yousefi Z, Sadeghi R. Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients: systematic review and meta-analysis of the literature. Gynecol Oncol. 2013;128(2):397–404.CrossRefPubMedGoogle Scholar
  19. 19.
    Goel JK, Kumar P. Cancer endometrium: an update. J South Asian Feder Obst Gynae. 2012;4(2):75–84.Google Scholar
  20. 20.
    Owen P, Duncan ID. Is there any value in the long term follow up of women treated for endometrial cancer? BJOG. 1996;103(7):710–3.CrossRefGoogle Scholar
  21. 21.
    Bristow RE, Purinton SC, Santillan A, Diaz-Montes TP, Gardner GJ, Giuntoli 2nd RL. Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance. Gynecol Oncol. 2006;103(2):709–13.CrossRefPubMedGoogle Scholar
  22. 22.
    Fung-Kee-Fung M, Dodge J, Elit L, Lukka H, Chambers A, Oliver T. Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol Oncol. 2006;101(3):520–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Shumsky AG, Stuart GC, Brasher PM, Nation JG, Robertson DI, Sangkarat S. An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol. 1994;55(2):229–33.CrossRefPubMedGoogle Scholar

Copyright information

© Springer India 2015

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyUniversity College of Medical Sciences and Guru Teg Bahadur HospitalDelhiIndia

Personalised recommendations